Long-Term Vitiligo Data Appear To Lay Opzelura Safety Concerns To Rest

 
• By Alaric DeArment
Incyte announced updated data for topical JAK inhibitor Opzelura in vitiligo • Source: Alamy

More from Dermatological

More from Therapeutic Category